tradingkey.logo

AngioDynamics Inc

ANGO
查看详细走势图
13.100USD
-0.060-0.46%
收盘 12/26, 16:00美东报价延迟15分钟
542.95M总市值
亏损市盈率 TTM

AngioDynamics Inc

13.100
-0.060-0.46%
盘中分时
1分
30分
1小时
日k
周k
月k
日k

今天

-0.46%

5天

-2.02%

1月

+6.50%

6月

+33.95%

今年开始到现在

+43.01%

1年

+47.03%

查看详细走势图

TradingKey AngioDynamics Inc股票评分

单位: USD 更新时间: 2025-12-26

操作建议

AngioDynamics Inc当前公司基本面数据相对健康,增长潜力很大。当前估值合理,在医疗设备与耗材行业排名24/207位。机构持股占比非常高,近一月多位分析师给出公司评级为买入。最高目标价18.50。中期看,股价处于上升通道。近一个月,市场表现较强,技术面和基本面综合得分较高,较强的走势得到基本面和技术面的印证。目前股价在压力位和支撑位之间,可以做区间波段操作。

AngioDynamics Inc评分

相关信息

行业排名
24 / 207
全市场排名
99 / 4563
所属行业
医疗设备与耗材

压力支撑

由于公司未披露,未能获取相关数据

多维评测

本期评分
上期评分

分析师目标

根据 4 位分析师
买入
评级
18.500
目标均价
+39.52%
涨幅空间
数据免责声明:分析师评级与目标价由LSEG提供,仅供参考,不应当作投资建议

AngioDynamics Inc亮点

亮点风险
AngioDynamics, Inc. is a transformative medical technology company. The Company is focused on restoring healthy blood flow in the body's vascular system, expanding cancer treatment options and improving quality of life for patients. It designs, manufactures, and sells a range of medical, surgical and diagnostic devices used by professional healthcare providers for vascular access, for the treatment of peripheral vascular disease and for use in oncology and surgical settings. Its devices are generally used in minimally invasive, image-guided procedures. Its segments include Med Tech and Med Device. Its product categories include oncology, venous therapies, vascular interventions, and ports. Its oncology products include Model 1500X RF Generator, IsoLoc Endorectal Balloon, Habib 4X Laparoscopic Bipolar Resection Device, Habib 4X Bipolar Resection Device, and Alatus. Its venous therapies include VenaCure EVLT 1470 Pro Laser, VenaCure EVLT System, VenaCure EVLT Procedure Packs, and others.
估值低估
公司最新PE估值-16.75,处于3年历史低位
机构减仓
最新机构持股40.19M股,环比减少0.03%
PRFDX持仓
明星投资者PRFDX持仓,最新持仓市值3.91K
活跃度降低
近期活跃度降低,过去20天平均换手率-0.36

AngioDynamics Inc新闻

即将为您带来更多新闻,敬请期待。。。

财务指标

每股收益

由于公司未披露,未能获取相关数据

营业总收入

由于公司未披露,未能获取相关数据

AngioDynamics Inc简介

AngioDynamics, Inc. is a transformative medical technology company. The Company is focused on restoring healthy blood flow in the body's vascular system, expanding cancer treatment options and improving quality of life for patients. It designs, manufactures, and sells a range of medical, surgical and diagnostic devices used by professional healthcare providers for vascular access, for the treatment of peripheral vascular disease and for use in oncology and surgical settings. Its devices are generally used in minimally invasive, image-guided procedures. Its segments include Med Tech and Med Device. Its product categories include oncology, venous therapies, vascular interventions, and ports. Its oncology products include Model 1500X RF Generator, IsoLoc Endorectal Balloon, Habib 4X Laparoscopic Bipolar Resection Device, Habib 4X Bipolar Resection Device, and Alatus. Its venous therapies include VenaCure EVLT 1470 Pro Laser, VenaCure EVLT System, VenaCure EVLT Procedure Packs, and others.
公司代码ANGO
公司AngioDynamics Inc
CEOClemmer (James C)
网址https://www.angiodynamics.com/

常见问题

AngioDynamics Inc(ANGO)的当前股价是多少?

AngioDynamics Inc(ANGO)的当前股价是 13.100。

AngioDynamics Inc的股票代码是什么?

AngioDynamics Inc的股票代码是ANGO。

AngioDynamics Inc股票的52周最高点是多少?

AngioDynamics Inc股票的52周最高点是13.990。

AngioDynamics Inc股票的52周最低点是多少?

AngioDynamics Inc股票的52周最低点是8.270。

AngioDynamics Inc的市值是多少?

AngioDynamics Inc的市值是542.95M。

AngioDynamics Inc的净利润是多少?

AngioDynamics Inc的净利润为-33.99M。

现在AngioDynamics Inc(ANGO)的股票是买入、持有还是卖出?

根据分析师评级,AngioDynamics Inc(ANGO)的总体评级为买入,目标价格为18.500。

AngioDynamics Inc(ANGO)股票的每股收益(EPS TTM)是多少

AngioDynamics Inc(ANGO)股票的每股收益(EPS TTM)是-0.782。
KeyAI